Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer

NCT00146588 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
55
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Craig A. Bunnell, MD, MPH

Collaborators